Patents by Inventor Gerard F. Barry

Gerard F. Barry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090240073
    Abstract: The invention relates in general to methods for detoxifying phosphonate herbicides. The methods may comprise transacetylating the phosphonate herbicide. The phosphonate herbicides can comprise a CP bond and a CN bond and may be glyphosate.
    Type: Application
    Filed: March 11, 2008
    Publication date: September 24, 2009
    Inventor: Gerard F. Barry
  • Patent number: 7554012
    Abstract: The invention relates in general to plants, plant cells, methods of making, and methods of using plants and plant cells transformed to express an acetyltransferase that transfers an acyl group to the terminal amine of AMPA, and to plants and plant cells exhibiting resistance to AMPA in an amount which inhibits the growth of a plant or plant cell lacking a sequence encoding the acetyltransferase.
    Type: Grant
    Filed: August 7, 2002
    Date of Patent: June 30, 2009
    Assignee: Monsanto Technology LLC
    Inventor: Gerard F. Barry
  • Publication number: 20040073976
    Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.
    Type: Application
    Filed: November 11, 2003
    Publication date: April 15, 2004
    Applicant: Monsanto Technology LLC
    Inventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
  • Patent number: 6716474
    Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: April 6, 2004
    Assignee: Monsanto Technology LLC
    Inventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
  • Patent number: 6663906
    Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: December 16, 2003
    Assignee: Monsanto Technology LLC
    Inventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
  • Publication number: 20030126641
    Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.
    Type: Application
    Filed: June 6, 2002
    Publication date: July 3, 2003
    Applicant: Monsanto Technology LLC
    Inventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
  • Publication number: 20030106096
    Abstract: The invention relates in general to herbicide resistance in plants, and more particularly to a new class of phosphonate metabolizing genes, and methods of using these genes for improving plant tolerance to phosphonate herbicides.
    Type: Application
    Filed: August 7, 2002
    Publication date: June 5, 2003
    Inventor: Gerard F. Barry
  • Publication number: 20020138875
    Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.
    Type: Application
    Filed: August 6, 2001
    Publication date: September 26, 2002
    Applicant: Monsanto Technology, LLC.
    Inventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
  • Patent number: 6448476
    Abstract: The invention relates in general to plants, plant cells, methods of making, and methods of using plants and plant cells transformed to contain a DNA sequence encoding an AMPA-N-acetyltransferase, and to plants and plant cells exhibiting resistance to AMPA in an amount which inhibits the growth of a plant or plant cell lacking a sequence encoding an AMPA-N-acetyltransferase.
    Type: Grant
    Filed: November 16, 1999
    Date of Patent: September 10, 2002
    Assignee: Monsanto Technology LLC
    Inventor: Gerard F. Barry
  • Patent number: 6441277
    Abstract: Fructose-1,6-bisphosphate aldolase (FDA) is an enzyme reversibly catalyzing the reaction converting triosephosphate into fructose-1,6-bisphosphate. In the leaf, this enzyme is located in the chloroplast (starch synthesis) and the cytosol (sucrose biosynthesis). Transgenic plants were generated that express the E. coli fda gene in the chloroplast to improve plant yield by increasing leaf starch biosynthetic ability in particular and sucrose production in general. Leaves from plants expressing the fda transgene showed a significantly higher starch accumulation, as compared to control plants expressing the null vector, particularly early in the photoperiod, but had lower leaf sucrose. Transgenic plants also had a significantly higher root mass. Furthermore, transgenic potatoes expressing fda exhibited improved uniformity of solids.
    Type: Grant
    Filed: June 16, 1998
    Date of Patent: August 27, 2002
    Assignee: Monsanto Technology LLC
    Inventors: Gerard F. Barry, Nordine Cheikh, Ganesh M. Kishore
  • Patent number: 5633435
    Abstract: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted transgenic crop field.
    Type: Grant
    Filed: September 13, 1994
    Date of Patent: May 27, 1997
    Assignee: Monsanto Company
    Inventors: Gerard F. Barry, Ganesh M. Kishore, Stephen R. Padgette, William C. Stallings
  • Patent number: 5627061
    Abstract: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted transgenic crop field.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 6, 1997
    Assignee: Monsanto Company
    Inventors: Gerard F. Barry, Ganesh M. Kishore, Stephen R. Padgette, William C. Stallings
  • Patent number: 5608149
    Abstract: Promoters for enhanced expression of ADPglucose pyrophosphorylase in potato tubers and fruits such as tomato; methods of using them; DNA molecules, plant cells and plants containing them. A method of decreasing the oil content of seeds by expression of ADPglucose pyrophosphorylase.
    Type: Grant
    Filed: March 3, 1995
    Date of Patent: March 4, 1997
    Assignee: Monsanto Company
    Inventors: Gerard F. Barry, Ganesh M. Kishore, David M. Stark
  • Patent number: 5536653
    Abstract: Promoters isolated from potato which cause expression of a gene of choice in tomato; tomato plant cells and plants containing them.
    Type: Grant
    Filed: November 4, 1994
    Date of Patent: July 16, 1996
    Assignee: Monsanto Company
    Inventors: Gerard F. Barry, Janice W. Edwards, Ganesh M. Kishore, David M. Stark
  • Patent number: 5498830
    Abstract: Promoters for enhanced expression of ADPglucose pyrophosphorylase in potato tubers and fruits such as tomato; methods of using them; DNA molecules, plant cells and plants containing them. A method of decreasing the oil content of seeds by expression of ADPglucose pyrophosphorylase.
    Type: Grant
    Filed: July 12, 1993
    Date of Patent: March 12, 1996
    Assignee: Monsanto Company
    Inventors: Gerard F. Barry, Ganesh M. Kishore, David M. Stark
  • Patent number: 5463175
    Abstract: Genes encoding a glyphosate oxidoreductase enzyme are disclosed. The genes are useful in producing transformed bacteria and plants which degrade glyphosate herbicide as well as crop plants which are tolerant to glyphosate herbicide.
    Type: Grant
    Filed: February 21, 1995
    Date of Patent: October 31, 1995
    Assignee: Monsanto Company
    Inventors: Gerard F. Barry, Ganesh M. Kishore
  • Patent number: RE38825
    Abstract: Genes encoding a glyphosate oxidoreductase enzyme are disclosed. The genes are useful in producing transformed bacteria and plants which degrade glyphosate herbicide as well as crop plants which are tolerant to glyphosate herbicide.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: October 11, 2005
    Assignee: Monsanto Technology LLC
    Inventors: Gerard F. Barry, Ganesh M. Kishore
  • Patent number: RE39247
    Abstract: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II EPSPS enzymes are characterized by being more kinetically efficient than Class I EPSPS's in the presence of glyphosate. Plants transformed with Class II EPSPS genes are also disclosed as well as a method for selectively controlling weeds in a planted transgenic crop field.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: August 22, 2006
    Assignee: Monsanto Technology LLC
    Inventors: Gerard F. Barry, Ganesh M. Kishore, Stephen R. Padgette, William C. Stallings